TLDR
- UnitedHealth reported weaker-than-expected Q4 2024 revenue
- CEO Andrew Witty addressed the murder of UnitedHealthcare CEO Brian Thompson
- Witty cited high medical service prices as root cause of healthcare proble
- Company wants healthcare to be less confusing, complex, and costly
- CEO highlighted price disparities, noting US anti-obesity drugs cost 10x more than in Europe
UnitedHealth Group CEO Andrew Witty addressed multiple challenges facing the healthcare giant during the company’s fourth-quarter earnings call, while paying tribute to murdered UnitedHealthcare CEO Brian Thompson.
The Minnesota-based health insurance and medical services company reported fourth-quarter 2024 earnings that fell below analysts’ expectations. The announcement led to a decline in the company’s share price during early morning trading, despite quarterly profits exceeding projections.
During the earnings call, Witty took time to acknowledge the tragic loss of Brian Thompson, who was fatally shot in Midtown Manhattan during the company’s annual investors conference last month. Thompson served as CEO of UnitedHealthcare, the health insurance division of UnitedHealth Group.
“Many of you knew Brian personally. You knew how much he meant to all of us and how he devoted his time to help make the health system work better for all of the people we’re privileged to serve,” Witty said during the call.
Witty praised Thompson’s dedication to improving healthcare experiences for various stakeholders, including individual consumers, employers, and public health agencies. He emphasized Thompson’s passionate approach to finding solutions that would benefit all parties involved.
The CEO then turned his attention to broader healthcare system challenges, identifying high prices for medical services as the “root cause” of America’s healthcare problems. He stressed that the current system needs substantial improvements in several areas.
“It needs to be less confusing, less complex and less costly,”
Witty stated, outlining three primary areas requiring attention in the US healthcare system.
In discussing specific cost challenges, Witty pointed to price disparities between the United States and other countries, particularly in pharmaceutical costs. He highlighted GLP-1 medications, used for diabetes and weight loss, as an example of pricing inequity.
The price difference for these medications is stark, with some anti-obesity drugs costing $900 in the United States while being available for just $90 in European markets.
The CEO also addressed criticism directed at the insurance industry regarding patient care decisions. This comes amid public outcry over insurance companies’ practices of denying and delaying crucial patient care while pursuing increased profits.
Witty defended the company’s commitment to its consumers while acknowledging the need for systemic improvements in healthcare delivery and accessibility.
The discussion of healthcare costs included criticism of both drug manufacturers and hospitals, with Witty suggesting that these entities contribute substantially to elevated healthcare expenses in the United States.
UnitedHealth Group, which operates both insurance and medical services divisions, maintains a unique perspective on healthcare costs due to its position in multiple sectors of the industry.
The company’s fourth-quarter performance reflects broader challenges in the healthcare sector, with revenue falling short of market expectations despite profit achievements.
Flags flew at half-staff outside UnitedHealthcare offices following Thompson’s death, symbolizing the impact of the loss on the organization and its employees.
The company continues to focus on its stated mission of improving healthcare accessibility and affordability while managing the transition following the loss of a key executive.
Stay Ahead of the Market with Benzinga Pro!
Want to trade like a pro? Benzinga Pro gives you the edge you need in today's fast-paced markets. Get real-time news, exclusive insights, and powerful tools trusted by professional traders:
- Breaking market-moving stories before they hit mainstream media
- Live audio squawk for hands-free market updates
- Advanced stock scanner to spot promising trades
- Expert trade ideas and on-demand support
